F16.151
Hallucinogen abuse with hallucinogen-induced psychotic disorder with hallucinations
Clinical Classification Guidelines
Medical Intelligence & Overview
Hallucinogen abuse combined with a hallucinogen-induced psychotic disorder is a serious mental health condition resulting from the misuse of substances that cause hallucinations. This condition is characterized by the presence of hallucinations and psychotic symptoms that are directly attributable to hallucinogenic drug use. Individuals experiencing this disorder often face significant challenges in perception, thinking, and emotional regulation, which can interfere with daily life and overall well-being.
Causes & Symptoms
Clinical Causes: Repeated or high-dose use of hallucinogenic substances such as LSD, psilocybin mushrooms, or peyote. Prolonged exposure to hallucinogens leading to persistent psychotic symptoms. Underlying mental health conditions that may predispose individuals to substance abuse and psychosis. Genetic susceptibility affecting how one's brain responds to hallucinogens. Environmental factors such as stressful life events or trauma that may contribute to substance misuse and psychosis development.
Key Symptoms: Visual hallucinations such as seeing shapes, colors, or figures that are not present. Auditory hallucinations like hearing voices or sounds without external stimuli. Paranoia or suspicious thinking about others' intentions. Disorganized thoughts and difficulty concentrating. Perceptual distortions affecting the sense of time, space, or body image. Emotional disturbances including anxiety, agitation, or fear. Possible flashbacks or re-experiencing hallucinations even after stopping drug use.
Diagnostic & Treatment
Diagnosis Path: Diagnosis typically involves a comprehensive clinical assessment including a detailed history of substance use and observing mental status. Healthcare providers may also perform psychiatric evaluations and, in some cases, imaging or laboratory tests to rule out other causes of psychosis. It is essential to distinguish between primary psychotic disorders and drug-induced psychosis to guide appropriate treatment.
Treatment Protocols: Managing hallucinogen abuse with psychotic features involves a multidimensional approach. Treatment options may include:
Clinical Advice & FAQs
Billing Guidance
Is F16.151 a billable ICD-10 code?
Yes, F16.151 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report F16.151?
Clinical documentation must specify the nature of Hallucinogen abuse with hallucinogen-induced psychotic disorder with hallucinations and any associated comorbidities for accurate reporting.
Cite this Clinical Reference